5[1]Serrano M, Hannon GJ, Beach DA,et al. A new regulatory modified in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993, 366:704 被引量：1
6[2]Sakata K, Tamura G, Maesawa C,et al. Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas. Jpn J Cancer, 1995, 86:333 被引量：1
7[3]Kim SK, Ro JY, Kemp BL,et al. Indentification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res, 1997, 57:400 被引量：1
8[4]Marchetti A, Buttitta F, Pellegrini S,et al. Alterations of p16(MST1) in node-positive non-small cell lung carcinomas. Journal of Pathology, 1997, 181:178 被引量：1
9[5]Shimizu T, Sekiya T. Loss of heterozygosity at 9 p21 loci and mutation of the MTS1 and MTS2 genes in human lung cancer. Int J Cancer, 1995, 63:616 被引量：1
10[6]Okamoto A, Hussain SP, Hagiwara K,et al. Mutations in the p16ink4a/MTS1/CDKN2, p15ink4b/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res, 1995, 55:1448 被引量：1
